Bank of Montreal
NUVB icon

Bank of Montreal’s Nuvation Bio NUVB Stock Holding History

Bank of Montreal’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-322,118
Closed -$496K – 4198
2023
Q4 		$496K Buy
+322,118
New +$415K ﹤0.01% 2510
2022
Q4 		– Sell
-19,546
Closed -$45 – 4196
2022
Q3 		$45 Buy
+19,546
New +$55.8K ﹤0.01% 3651

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Bank of Montreal's NUVB Position: Q1 2024 in Review

Bank of Montreal sold out of Nuvation Bio (NUVB) in Q1 2024, closing a stake of 322,118 shares — an estimated $496K sold.

Bank of Montreal first reported a position in NUVB in Q3 2022 and held it in 2 quarters. The position peaked at $496K in Q4 2023. 124 funds tracked by Wall St. Rank hold NUVB as of Q1 2024.

  • Bank of Montreal reported no remaining Nuvation Bio position as of Q1 2024 after selling out during the quarter.
  • Bank of Montreal sold 322,118 Nuvation Bio shares in Q1 2024, an estimated $496K.
  • Bank of Montreal first reported a position in Nuvation Bio in Q3 2022 and held it in 2 quarters.
  • Bank of Montreal's Nuvation Bio position peaked at $496K in Q4 2023.
  • 124 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2024.

Based on Bank of Montreal's 13F filing for Q1 2024, filed 13 May 2024.